RTI Health Solutions
@rti-hs.bsky.social
We partner with pharmaceutical and medical device developers to provide critical strategy and integrated evidence generation throughout product development lifecycles. www.rtihs.org
ISPOR Europe 2025 highlighted that patient voice drives #HTA, value, and access. PROs, COAs, preference evidence, real-world data, and #JCA all matter — integrate early for stronger, decision-ready submissions. Read more: ow.ly/9XnQ50XFTuS
December 8, 2025 at 7:19 PM
ISPOR Europe 2025 highlighted that patient voice drives #HTA, value, and access. PROs, COAs, preference evidence, real-world data, and #JCA all matter — integrate early for stronger, decision-ready submissions. Read more: ow.ly/9XnQ50XFTuS
ow.ly/y4I550XuUw1 EU Joint Clinical Assessments are reshaping orphan drug access in Europe.
Download RTI Health Solutions’ free report for the key challenges, evidence needs, and strategies to stay ahead.
#OrphanDrugs #RareDisease #JCA
Download RTI Health Solutions’ free report for the key challenges, evidence needs, and strategies to stay ahead.
#OrphanDrugs #RareDisease #JCA
November 20, 2025 at 7:34 PM
ow.ly/y4I550XuUw1 EU Joint Clinical Assessments are reshaping orphan drug access in Europe.
Download RTI Health Solutions’ free report for the key challenges, evidence needs, and strategies to stay ahead.
#OrphanDrugs #RareDisease #JCA
Download RTI Health Solutions’ free report for the key challenges, evidence needs, and strategies to stay ahead.
#OrphanDrugs #RareDisease #JCA
We're excited to announce that we've expanded our collaboration with Bekhealth and Innovo Research to set a new standard for how EHR data is transformed into actionable intelligence for clinical research and RWE. -> ow.ly/kqFm50Xo1mB #drugdevelopment #HealthOutcomes 🧪 PharmSky Medsky
November 7, 2025 at 2:41 PM
We're excited to announce that we've expanded our collaboration with Bekhealth and Innovo Research to set a new standard for how EHR data is transformed into actionable intelligence for clinical research and RWE. -> ow.ly/kqFm50Xo1mB #drugdevelopment #HealthOutcomes 🧪 PharmSky Medsky
What happens when you need clear, expert-driven guidance on when and how a therapy should be used in clinical practice? We used a Delphi panel approach—bringing together expert consensus to inform treatment guidelines. See the case study -> ow.ly/e09o50WxrFb 🧪 PharmSky Medsky #medaffairs
September 25, 2025 at 11:21 AM
What happens when you need clear, expert-driven guidance on when and how a therapy should be used in clinical practice? We used a Delphi panel approach—bringing together expert consensus to inform treatment guidelines. See the case study -> ow.ly/e09o50WxrFb 🧪 PharmSky Medsky #medaffairs
What happens when you need clear, expert-driven guidance on when and how a therapy should be used in clinical practice? We used a Delphi panel approach—bringing together expert consensus to inform treatment guidelines for a client’s therapy. See the case study -> ow.ly/e09o50WxrFb 🧪 PharmSky Medsky
Delphi Panel on Proper Use of Anticoagulant Reversal Therapy in Life-Threatening Bleeds
Guiding the use of a treatment for life-threatening bleeds and creating convenient guides for emergency clinicians.
ow.ly
September 24, 2025 at 12:28 PM
What happens when you need clear, expert-driven guidance on when and how a therapy should be used in clinical practice? We used a Delphi panel approach—bringing together expert consensus to inform treatment guidelines for a client’s therapy. See the case study -> ow.ly/e09o50WxrFb 🧪 PharmSky Medsky
ow.ly/AksJ50WYfNS
🚀 Pharma innovation doesn’t end at approval—it begins with adoption. Why do some breakthrough therapies struggle to gain traction in the real world? Our latest whitepaper explores how Implementation Science can bridge the gap.
🧪 PharmSky Medsky
🚀 Pharma innovation doesn’t end at approval—it begins with adoption. Why do some breakthrough therapies struggle to gain traction in the real world? Our latest whitepaper explores how Implementation Science can bridge the gap.
🧪 PharmSky Medsky
September 18, 2025 at 1:16 PM
ow.ly/AksJ50WYfNS
🚀 Pharma innovation doesn’t end at approval—it begins with adoption. Why do some breakthrough therapies struggle to gain traction in the real world? Our latest whitepaper explores how Implementation Science can bridge the gap.
🧪 PharmSky Medsky
🚀 Pharma innovation doesn’t end at approval—it begins with adoption. Why do some breakthrough therapies struggle to gain traction in the real world? Our latest whitepaper explores how Implementation Science can bridge the gap.
🧪 PharmSky Medsky
Smarter pharma research starts with responsible AI. RTI Health Solutions is leading the way with:
✅ Validated Artificial Intelligence tools
✅ Human oversight
✅ Global compliance
Let’s innovate with integrity.🔗Learn more about our approach at ow.ly/sN4550WXs2c #PharmaInnovation 🧪 PharmSky Medsky
✅ Validated Artificial Intelligence tools
✅ Human oversight
✅ Global compliance
Let’s innovate with integrity.🔗Learn more about our approach at ow.ly/sN4550WXs2c #PharmaInnovation 🧪 PharmSky Medsky
September 16, 2025 at 1:43 PM
Smarter pharma research starts with responsible AI. RTI Health Solutions is leading the way with:
✅ Validated Artificial Intelligence tools
✅ Human oversight
✅ Global compliance
Let’s innovate with integrity.🔗Learn more about our approach at ow.ly/sN4550WXs2c #PharmaInnovation 🧪 PharmSky Medsky
✅ Validated Artificial Intelligence tools
✅ Human oversight
✅ Global compliance
Let’s innovate with integrity.🔗Learn more about our approach at ow.ly/sN4550WXs2c #PharmaInnovation 🧪 PharmSky Medsky
Developing an ultra-rare disease therapy? Identifying a suitable comparator for pricing and reimbursement can be a big hurdle. Here's how we helped a client navigate complex global market access challenges with a strategic roadmap for regional value dossiers. ow.ly/NsNB50WxspH 🧪 PharmSky Medsky
September 11, 2025 at 12:05 PM
Developing an ultra-rare disease therapy? Identifying a suitable comparator for pricing and reimbursement can be a big hurdle. Here's how we helped a client navigate complex global market access challenges with a strategic roadmap for regional value dossiers. ow.ly/NsNB50WxspH 🧪 PharmSky Medsky
What a week at #ISPEAnnual2025 in DC!
From powerful sessions to meaningful connections, we left inspired.
💡 Check out the research we presented and follow-up with our team at ow.ly/V8Ee50WRx0R
From powerful sessions to meaningful connections, we left inspired.
💡 Check out the research we presented and follow-up with our team at ow.ly/V8Ee50WRx0R
September 4, 2025 at 8:54 PM
What a week at #ISPEAnnual2025 in DC!
From powerful sessions to meaningful connections, we left inspired.
💡 Check out the research we presented and follow-up with our team at ow.ly/V8Ee50WRx0R
From powerful sessions to meaningful connections, we left inspired.
💡 Check out the research we presented and follow-up with our team at ow.ly/V8Ee50WRx0R
Are you leveraging Implementation Science in your Pharma or MedTech research? This proactive, evidence-based model helps anticipate and overcome barriers to adoption—accelerating the integration of innovative therapies into clinical practice. Download the whitepaper at go.rti.org/LeverageImpSci
September 4, 2025 at 1:27 PM
Are you leveraging Implementation Science in your Pharma or MedTech research? This proactive, evidence-based model helps anticipate and overcome barriers to adoption—accelerating the integration of innovative therapies into clinical practice. Download the whitepaper at go.rti.org/LeverageImpSci
The TARGET Guideline for target trial emulation is now publicly available. This new guideline will improve reporting transparency of studies using real-world data to emulate a pragmatic randomized trial and improve clarity, completeness, and credibility of findings. Learn more at ow.ly/vLpa50WPPHr
September 3, 2025 at 3:17 PM
The TARGET Guideline for target trial emulation is now publicly available. This new guideline will improve reporting transparency of studies using real-world data to emulate a pragmatic randomized trial and improve clarity, completeness, and credibility of findings. Learn more at ow.ly/vLpa50WPPHr
🧬 A biopharmaceutical company needed to validate its health economic model for a rare disease across healthcare systems. See how RTI Health Solutions helped them navigate regional complexities and ensure their model stood up to scrutiny. ow.ly/t9ek50WxrwX Pharma Strategy, Value Assessment
August 21, 2025 at 2:54 PM
🧬 A biopharmaceutical company needed to validate its health economic model for a rare disease across healthcare systems. See how RTI Health Solutions helped them navigate regional complexities and ensure their model stood up to scrutiny. ow.ly/t9ek50WxrwX Pharma Strategy, Value Assessment
Join our webinar on the challenges and early learnings surrounding JCA guidelines for orphan drug development. Whether you're preparing for your first JCA submission or refining your approach, this session offers valuable insights.
📅 24 September 2025, 16:00 CEST/10:00 EDT
🔗 ow.ly/bQZ150WFVA0
📅 24 September 2025, 16:00 CEST/10:00 EDT
🔗 ow.ly/bQZ150WFVA0
Webinar: EU Joint Clinical Assessment for Orphan Drugs
Join our expert-led webinar on the EU Joint Clinical Assessment for orphan drugs to learn challenges and strategies for rare disease submissions
ow.ly
August 14, 2025 at 12:04 PM
Join our webinar on the challenges and early learnings surrounding JCA guidelines for orphan drug development. Whether you're preparing for your first JCA submission or refining your approach, this session offers valuable insights.
📅 24 September 2025, 16:00 CEST/10:00 EDT
🔗 ow.ly/bQZ150WFVA0
📅 24 September 2025, 16:00 CEST/10:00 EDT
🔗 ow.ly/bQZ150WFVA0
🌟 Empowering the Next Generation of Women in STEM! 🌟
We're proud to share that Mei Grace, Sr Research Health Economist at RTI-HS, spoke at Girls Talk Math at UNC Chapel Hill, inspiring students with her STEM journey. Her story sparked curiosity, engagement, and highlighted the power of mentorship.
We're proud to share that Mei Grace, Sr Research Health Economist at RTI-HS, spoke at Girls Talk Math at UNC Chapel Hill, inspiring students with her STEM journey. Her story sparked curiosity, engagement, and highlighted the power of mentorship.
Mei Grace
MSc, MathematicsWake Forest University, Winston Salem, NC BS, MathematicsUniversity of Vermont, Burlington, VT
www.rtihs.org
August 6, 2025 at 11:38 AM
🌟 Empowering the Next Generation of Women in STEM! 🌟
We're proud to share that Mei Grace, Sr Research Health Economist at RTI-HS, spoke at Girls Talk Math at UNC Chapel Hill, inspiring students with her STEM journey. Her story sparked curiosity, engagement, and highlighted the power of mentorship.
We're proud to share that Mei Grace, Sr Research Health Economist at RTI-HS, spoke at Girls Talk Math at UNC Chapel Hill, inspiring students with her STEM journey. Her story sparked curiosity, engagement, and highlighted the power of mentorship.
We’re proud to announce that we have earned a Bronze Medal Sustainability Rating from EcoVadis. This is a testament to our commitment to incorporate sustainable practices into our operations, ensuring we positively impact the environment and society. Learn more at ow.ly/zXj350WnUi1
RTI Health Solutions Recognized for Sustainable Management System
RTI Health Solutions has earned a Bronze Medal, a recognition awarded to the Top 35% of companies assessed by EcoVadis for the sustainability of the company's management system and commitment to promo...
ow.ly
July 16, 2025 at 12:18 PM
We’re proud to announce that we have earned a Bronze Medal Sustainability Rating from EcoVadis. This is a testament to our commitment to incorporate sustainable practices into our operations, ensuring we positively impact the environment and society. Learn more at ow.ly/zXj350WnUi1
There was an invigorating atmosphere of cooperation at the recent focusing on the 6-month assessment of new EU HTA, JCA regulation. Several of our researchers attended and share key insights. Read their observations here: ow.ly/HM1750WmB2Q 🧪 PharmSky Medsky HTA
A New Era of Collaboration for EU Health Technology Assessment
Learn about developments in the EU HTA regulation and the role of collaboration, AI, and capacity building in shaping the future of healthcare.
ow.ly
July 9, 2025 at 12:27 PM
There was an invigorating atmosphere of cooperation at the recent focusing on the 6-month assessment of new EU HTA, JCA regulation. Several of our researchers attended and share key insights. Read their observations here: ow.ly/HM1750WmB2Q 🧪 PharmSky Medsky HTA
Next week on June 18, our experts will be hosting a webinar where they discuss methods and guidelines for establishing surrogate outcomes. Learn how they have been used in health technology assessments to date. Register today! ow.ly/BA9r50VOqLt 🧪 PharmSky Medsky HTA
Webinar: Surrogate Outcomes in Health Technology Assessment - Accelerating Access to Breakthrough Treatments
Surrogate outcomes play an important role in modern healthcare research. Join us for this webinar where our experts will focus on methods and guidelines for establishing surrogate outcomes and how the...
ow.ly
June 10, 2025 at 12:27 PM
Next week on June 18, our experts will be hosting a webinar where they discuss methods and guidelines for establishing surrogate outcomes. Learn how they have been used in health technology assessments to date. Register today! ow.ly/BA9r50VOqLt 🧪 PharmSky Medsky HTA
There's a lot of debate surrounding the use of artificial intelligence tools in research. At RTI Health Solutions, we prioritize responsible #AI use by adhering to these 5 key principles. ow.ly/riV150W3f6c Responsible AI, Human in the Loop, pharmaceutical development
Artificial Intelligence in Health Science: Advancing Research Responsibly and Ethically
While the use of artificial intelligence holds great promise, it also comes with risk. We help clients understand how to effectively use AI in their research.
ow.ly
June 3, 2025 at 12:46 PM
There's a lot of debate surrounding the use of artificial intelligence tools in research. At RTI Health Solutions, we prioritize responsible #AI use by adhering to these 5 key principles. ow.ly/riV150W3f6c Responsible AI, Human in the Loop, pharmaceutical development
RTI-HS experts share 5 critical steps during rare disease drug development that can help prepare your orphan drug to progress through joint clinical assessments (JCA). ow.ly/Q28e50VVWOJ 🧪 PharmSky Medsky
Joint Clinical Assessment and Orphan Drugs: 5 Steps to Success
JCAs will apply to orphan medicines starting in 2028. We’d like to share some of what we’ve learned from working on JCA submissions.
ow.ly
May 21, 2025 at 12:40 PM
RTI-HS experts share 5 critical steps during rare disease drug development that can help prepare your orphan drug to progress through joint clinical assessments (JCA). ow.ly/Q28e50VVWOJ 🧪 PharmSky Medsky
Hi Chris! Welcome to Bluesky. So glad you're here. 😃 - Samantha @csimmons913.bsky.social
May 21, 2025 at 12:38 PM
Hi Chris! Welcome to Bluesky. So glad you're here. 😃 - Samantha @csimmons913.bsky.social
Discover how the pharmaceutical industry can leverage implementation science to identify gaps and opportunities, enabling companies to craft research that aligns with long-term goals and delivers tangible value to all decision-makers. ow.ly/LAHU50VSPQS 🧪 PharmSky Medsky #ISPORAnnual
Why Implementation Science is Vital for Pharma Innovation
Learn how implementation science helps pharma improve adoption, outcomes, and value by embedding sustainable strategies into existing workflows.
ow.ly
May 15, 2025 at 1:21 PM
Discover how the pharmaceutical industry can leverage implementation science to identify gaps and opportunities, enabling companies to craft research that aligns with long-term goals and delivers tangible value to all decision-makers. ow.ly/LAHU50VSPQS 🧪 PharmSky Medsky #ISPORAnnual
You are invited to our June 18 webinar: Surrogate Outcomes in HTA. Explore real-world examples and challenges around using surrogate outcomes in HTAs, with examples in cardiovascular disease, oncology, and obesity. Learn more and register here ow.ly/BA9r50VOqLt 🧪 PharmSky Medsky
Webinar: Surrogate Outcomes in Health Technology Assessment - Accelerating Access to Breakthrough Treatments
Surrogate outcomes play an important role in modern healthcare research. Join us for this webinar where our experts will focus on methods and guidelines for establishing surrogate outcomes and how the...
ow.ly
May 7, 2025 at 1:29 PM
You are invited to our June 18 webinar: Surrogate Outcomes in HTA. Explore real-world examples and challenges around using surrogate outcomes in HTAs, with examples in cardiovascular disease, oncology, and obesity. Learn more and register here ow.ly/BA9r50VOqLt 🧪 PharmSky Medsky
Learn the signs of research futility, from data limitations to ethical concerns, and when to discontinue observational studies for scientific integrity. ow.ly/viaY50V2PES @John Seeger #observationalresearch #researchethics 🧪PharmSky #realworldevidence
Recognizing Futility in Research: When to Consider Discontinuing Observational Research
Learn the signs of research futility, from data limitations to ethical concerns, and when to discontinue observational studies for scientific integrity.
ow.ly
May 7, 2025 at 12:14 PM
Learn the signs of research futility, from data limitations to ethical concerns, and when to discontinue observational studies for scientific integrity. ow.ly/viaY50V2PES @John Seeger #observationalresearch #researchethics 🧪PharmSky #realworldevidence
We are very proud that RTI has been recognized as one of America's Greenest Companies by Newsweek! We are serious about our commitment to corporate responsibility and #sustainability. Read more about this award. ow.ly/R1s550TWITy 🧪 PharmSky @rti.bsky.social
RTI recognized by Newsweek as one of America’s Greenest Companies
RTI was recognized as one of America’s Greenest Companies by Newsweek and Plant-A Insights Group in collaboration with GIST Impact.
ow.ly
April 29, 2025 at 3:34 PM
We are very proud that RTI has been recognized as one of America's Greenest Companies by Newsweek! We are serious about our commitment to corporate responsibility and #sustainability. Read more about this award. ow.ly/R1s550TWITy 🧪 PharmSky @rti.bsky.social
The responsible use of AI tools in evidence synthesis is paramount. Thorough evaluation before deployment ensures that tools enhance efficiency without compromising quality. Jose Marcano Belisario, PhD of RTI Health Solutions shares his insights. ow.ly/myTL50VGjRf #ResponsibleAI 🧪 PharmSky Medsky
Harnessing AI Tools for Enhanced Evidence Synthesis: Lessons Learned
AI holds immense potential to address one of the most significant challenges in evidence synthesis: the sheer volume of work. See more.
ow.ly
April 24, 2025 at 1:07 PM
The responsible use of AI tools in evidence synthesis is paramount. Thorough evaluation before deployment ensures that tools enhance efficiency without compromising quality. Jose Marcano Belisario, PhD of RTI Health Solutions shares his insights. ow.ly/myTL50VGjRf #ResponsibleAI 🧪 PharmSky Medsky